An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States
Conditions: Advanced Gastrointestinal Stromal Tumor Interventions: Drug: Regorafenib (Stivarga, BAY73-4506) Sponsors: Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Gastroenterology | Gastrointestinal Stromal Tumor (GIST) | Learning | Research | Study | Universities & Medical Training | USA Health